Cargando…
How will the field of gene therapy survive its success?
In August 2017, for the first time, a gene therapy was approved for market release in the United States. That approval was followed by two others before the end of the year. This article cites primary literature, review articles concerning particular biotechnologies, and press releases by the FDA an...
Autor principal: | Kaemmerer, William F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063870/ https://www.ncbi.nlm.nih.gov/pubmed/30065971 http://dx.doi.org/10.1002/btm2.10090 |
Ejemplares similares
-
The effects of huntingtin-lowering: what do we know so far?
por: Kaemmerer, William F, et al.
Publicado: (2019) -
How the CMS collaboration orchestrates its success
Publicado: (2012) -
Born to survive: how cancer cells resist CAR T cell therapy
por: Lemoine, Jean, et al.
Publicado: (2021) -
Influence of risk factors and comorbidities on the successful therapy and survival of patients with critical limb ischemia
por: CONSTANTINESCU, MIHAELA IOANA, et al.
Publicado: (2013) -
How to Make a Success of Your Marriage
Publicado: (1953)